share_log

心動公司:翌日披露報表 (已發行股本變動)

XD INC: Next Day Disclosure Return (changes in issued share capital)

香港交易所 ·  Apr 11 06:46
Summary by Moomoo AI
心動公司於2024年4月11日根據其於2021年6月25日採納的購股權計劃,向合資格參與者發行了共計39,800股普通股。其中7,200股以每股9.31港元發行,32,600股以每股13.284港元發行,分別較上一個營業日的收市價14.74港元折讓36.84%及9.88%。此次發行後,心動公司的已發行股本由480,526,707股增至480,566,507股。公司確認,所有發行均已獲董事會批准,並已收取全部款項,符合上市規則的所有要求。
心動公司於2024年4月11日根據其於2021年6月25日採納的購股權計劃,向合資格參與者發行了共計39,800股普通股。其中7,200股以每股9.31港元發行,32,600股以每股13.284港元發行,分別較上一個營業日的收市價14.74港元折讓36.84%及9.88%。此次發行後,心動公司的已發行股本由480,526,707股增至480,566,507股。公司確認,所有發行均已獲董事會批准,並已收取全部款項,符合上市規則的所有要求。
Cardio Corporation issued a total of 39,800 shares of ordinary shares to eligible participants on April 11, 2024 under its share option plan adopted on June 25, 2021. Of these, 7,200 shares were issued at HK$9.31 per share and 32,600 shares were issued at HK$13.284 per share, representing a decrease of 36.84% and 9.88% from the closing price of HK$14.74 on the previous business day. Following the issuance, the issued share capital of the Company increased from 480,526,707 shares to 480,566,507 shares. The Company confirms that all issues have been approved by the Board of Directors and that all monies have been received in compliance with all requirements of the Listing Rules.
Cardio Corporation issued a total of 39,800 shares of ordinary shares to eligible participants on April 11, 2024 under its share option plan adopted on June 25, 2021. Of these, 7,200 shares were issued at HK$9.31 per share and 32,600 shares were issued at HK$13.284 per share, representing a decrease of 36.84% and 9.88% from the closing price of HK$14.74 on the previous business day. Following the issuance, the issued share capital of the Company increased from 480,526,707 shares to 480,566,507 shares. The Company confirms that all issues have been approved by the Board of Directors and that all monies have been received in compliance with all requirements of the Listing Rules.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more